Merck KGaA
MKGAF
$133.31
-$0.20-0.15%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.09B | 22.88B | 22.88B | 22.73B | 22.57B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.09B | 22.88B | 22.88B | 22.73B | 22.57B |
| Cost of Revenue | 9.54B | 9.29B | 9.34B | 9.37B | 9.39B |
| Gross Profit | 13.55B | 13.59B | 13.55B | 13.37B | 13.19B |
| SG&A Expenses | 6.46B | 6.38B | 6.37B | 6.21B | 6.20B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 292.97M | 490.38M | 448.77M | 704.06M | 612.48M |
| Total Operating Expenses | 18.61B | 18.56B | 18.61B | 18.90B | 18.87B |
| Operating Income | 4.48B | 4.32B | 4.27B | 3.84B | 3.70B |
| Income Before Tax | 3.96B | 3.86B | 3.83B | 3.66B | 3.53B |
| Income Tax Expenses | 830.08M | 826.34M | 814.05M | 721.87M | 682.34M |
| Earnings from Continuing Operations | 3.13K | 3.03K | 3.02K | 2.94K | 2.85K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -13.06M | -7.50M | -9.77M | -8.73M | -7.61M |
| Net Income | 3.11B | 3.03B | 3.01B | 2.93B | 2.84B |
| EBIT | 4.48B | 4.32B | 4.27B | 3.84B | 3.70B |
| EBITDA | 6.35B | 6.18B | 6.13B | 5.69B | 5.54B |
| EPS Basic | 7.16 | 6.97 | 6.92 | 6.74 | 6.55 |
| Normalized Basic EPS | 6.26 | 6.14 | 6.09 | 5.56 | 5.38 |
| EPS Diluted | 7.16 | 6.97 | 6.92 | 6.73 | 6.54 |
| Normalized Diluted EPS | 6.26 | 6.14 | 6.09 | 5.56 | 5.38 |
| Average Basic Shares Outstanding | 1.74B | 1.74B | 1.74B | 1.74B | 1.74B |
| Average Diluted Shares Outstanding | 1.74B | 1.74B | 1.74B | 1.74B | 1.74B |
| Dividend Per Share | 2.35 | 2.35 | 2.35 | 2.37 | 2.37 |
| Payout Ratio | 37.75% | 36.37% | 36.88% | 37.89% | 39.03% |